{"id":"NCT02655237","sponsor":"Takeda","briefTitle":"A Phase 3 Study to Evaluate the Efficacy and Safety of Relugolix (TAK-385) 40 mg Compared With Leuprorelin in the Treatment of Uterine Fibroids","officialTitle":"A Multicenter, Randomized, Double-Blind, Parallel-Group, Phase 3 Study to Evaluate the Efficacy and Safety of Oral TAK-385 40 mg Compared With Leuprorelin in the Treatment of Uterine Fibroids","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-03-05","primaryCompletion":"2017-05-17","completion":"2017-09-25","firstPosted":"2016-01-13","resultsPosted":"2019-03-22","lastUpdate":"2019-03-22"},"enrollment":281,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Uterine Fibroids"],"interventions":[{"type":"DRUG","name":"Relugolix","otherNames":["TAK-385"]},{"type":"DRUG","name":"Relugolix Placebo","otherNames":[]},{"type":"DRUG","name":"Leuprorelin","otherNames":[]},{"type":"DRUG","name":"Leuprorelin Placebo","otherNames":[]}],"arms":[{"label":"Relugolix 40 mg","type":"EXPERIMENTAL"},{"label":"Leuprorelin 1.88 mg or 3.75 mg","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to evaluate the efficacy of Relugolix (TAK-385) 40 mg administered orally once daily for 12 weeks, compared with leuprorelin injection (once every 4 weeks, 1.88 mg or 3.75 mg subcutaneously \\[SC\\]/time) in patients with uterine fibroids.","primaryOutcome":{"measure":"Percentage of Participants With Total PBAC Score of <10 From Week 6 to 12","timeFrame":"Week 6 to 12","effectByArm":[{"arm":"Relugolix 40 mg","deltaMin":82.2,"sd":null},{"arm":"Leuprorelin 1.88 mg or 3.75 mg","deltaMin":83.1,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0013"}]},"eligibility":{"minAge":"20 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":25,"countries":["Japan"]},"refs":{"pmids":["30741797"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":138},"commonTop":["Metrorrhagia","Hot flush","Viral upper respiratory tract infection","Menorrhagia","Headache"]}}